Instil Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Instil Bio, Inc. (TIL) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents8.819.2043.72454.10241.71
Short-Term Investments104.51141.16217.20416.510.00
Cash & Short-Term Investments113.32151.41263.12454.10241.71
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets11.167.856.262.344.42
Total Current Assets124.47160.76269.38464.02246.14
Non-Current Assets
Property, Plant & Equipment (Net)130.34141.07209.34122.0055.34
Long-Term Investments0.0023.160.000.000.00
Goodwill0.000.000.005.725.72
Intangible Assets0.000.000.0010.1010.10
Other Non-Current Assets8.760.643.418.141.21
Total Non-Current Assets139.10164.87212.75145.960.00
Total Assets263.57325.63482.13609.98319.01
Current Liabilities
Accounts Payable0.661.212.365.573.50
Short-Term Debt1.680.000.000.000.00
Accrued Liabilities2.864.279.3021.457.19
Other Current Liabilities5.563.3318.7535.791.97
Total Current Liabilities7.9010.5632.7941.3613.28
Non-Current Liabilities
Long-Term Debt85.2081.4372.350.000.00
Deferred Tax Liabilities0.000.000.002.432.47
Other Non-Current Liabilities1.034.948.2111.0010.89
Total Non-Current Liabilities86.2489.2485.7413.430.00
Total Liabilities94.1399.80118.5254.7826.65
Stockholders' Equity
Retained Earnings-655.12-580.98-424.89-201.80-44.92
Accumulated Other Comprehensive Income-0.23-0.35-0.49-0.09-0.28
Additional Paid-in Capital824.78807.16788.99757.000.00
Shares Outstanding6.536.506.506.450.00
Total Stockholders' Equity169.44225.83363.61555.20292.37
Total Liabilities & Equity263.57325.63482.13609.980.00